C9311 HCPCS Level II code: Injection, eplontersen, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self…
C9311 is the HCPCS code for “Injection, eplontersen, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
C9311Injection, eplontersen, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
Short description: Inj, eplontersen, 1 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with C9311 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Statute
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Other drugs
- Coverage statute
- 1833(t)
- Added
- Oct 1, 2026
Where C9311 sits
- 1C codesOutpatient prospective payment system
- 2Active code C9311Injection, eplontersen, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code C9311 mean?
C9311 is the HCPCS code for “Injection, eplontersen, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover C9311?
CMS lists C9311’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Statute”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside C9311
All C codesC9305Injection, nipocalimab-aahu, 3 mgC9306Injection, telisotuzumab vedotin-tllv, 1 mgC9307Injection, linvoseltamab-gcpt, 1 mgC9308Injection, carboplatin (avyxa), 1 mgC9309Injection, onasemnogene abeparvovec-brve, per treatmentC9310Injection, leucovorin calcium (avyxa), 1 mgC9312Injection, trabectedin (apotex), not therapeutically equivalent to j9362, 0.01 mgC9313Injection, pivekimab sunirine-pvzy, 0.01 mgC9349Puraply, and puraply antimicrobial, any type, per square centimeterC9352Microporous collagen implantable tube (neuragen nerve guide), per centimeter lengthC9353Microporous collagen implantable slit tube (neurawrap nerve protector), per centimeter lengthC9354Acellular pericardial tissue matrix of non-human origin (veritas), per square centimeter